Overview

Azithromycin Treatment for the Airway Microbiome in Asthma

Status:
Active, not recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study to determine whether the bacteria inside the lungs of people with asthma can be modified (changed) if they are given an antibiotic and if this change is associated with an improvement in asthma symptoms.
Phase:
Phase 2
Details
Lead Sponsor:
University of Chicago
Collaborator:
Northwestern University
Treatments:
Azithromycin